Ingrid Arijs

7PUBLICATIONS
70CO-AUTHORS
Predictive and prognostic markersInfectious diseasesMedical infection agents (incl. prions)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 29, 2024
Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients.

Tom Venken, Ian S Miller, Ingrid Arijs

|Nov 29, 2023
PD-1<sup>-</sup> CD45RA<sup>+</sup> effector-memory CD8 T cells and CXCL10<sup>+</sup> macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma.

Sarah Cappuyns, Gino Philips, Vincent Vandecaveye

|Nov 29, 2023
A Core Outcome Set for Inflammatory Bowel Diseases: Development and Recommendations for Implementation in Clinical Practice Through an International Multi-stakeholder Consensus Process.

Liselotte Fierens, Nicholas Carney, Gottfried Novacek

|Feb 25, 2022
The Dynamics of Nucleotide Variants in the Progression from Low-Intermediate Myeloma Precursor Conditions to Multiple Myeloma: Studying Serial Samples with a Targeted Sequencing Approach.

Bénedith Oben, Charlotte Cosemans, Ellen Geerdens

|Jul 06, 2021
Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.

L Vanderbeke, P Van Mol, Y Van Herck

|May 07, 2021
A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer.

Ayse Bassez, Hanne Vos, Laurien Van Dyck

Pageof 2

Frequent Collaborators

4 joint publications

Diether Lambrechts

2 joint publications

Junbin Qian

2 joint publications

Guy Froyen

2 joint publications

Abhishek D Garg